Operating cash flow decreased 94.4%
Operating cash flow changed -94.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$25.8M→$1.4M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →AZTA financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income decreased 485.2%
Operating income changed -485.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-$714,000→-$4.2M2 prior comparisons
Operating margin moved 210 bp lower
Operating margin changed -210 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-0.50%→-2.59%2 prior comparisons
Gross margin moved 218 bp lower
Gross margin changed -218 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
47.07%→44.89%2 prior comparisons
Cash & equivalents decreased 29.8%
Cash & equivalents changed -29.8% from the comparable as-filed period.
$270.0M→$189.7M3 prior comparisons
Capex / revenue moved 341 bp lower
Capex / revenue changed -341 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
7.53%→4.12%2 prior comparisons
Research & development increased 32.4%
Research & development changed +32.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$6.7M→$8.9M2 prior comparisons
Free-cash-flow proxy changed across a sign change
Free-cash-flow proxy changed -134.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
$15.0M→-$5.2M2 prior comparisons
Revenue increased 12.0%
Revenue changed +12.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$143.9M→$161.2M2 prior comparisons
Stock-based compensation increased 111.8%
Stock-based compensation changed +111.8% from the comparable as-filed period.
$2.2M→$4.7M2 prior comparisons
Capital expenditure decreased 38.7%
Capital expenditure changed -38.7% from the comparable as-filed period.
$10.8M→$6.6M2 prior comparisons
Inventory / revenue moved 686 bp lower
Inventory / revenue changed -686 basis points from the comparable as-filed period.
55.93%→49.07%0 prior comparisons
Free-cash-flow margin moved 1362 bp lower
Free-cash-flow margin changed -1362 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
10.40%→-3.22%2 prior comparisons
Operating cash-flow margin moved 1703 bp lower
Operating cash-flow margin changed -1703 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
17.93%→0.90%2 prior comparisons
Trade receivables increased 15.4%
Trade receivables changed +15.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$124.5M→$143.7M2 prior comparisons
Net income changed across a sign change
Net income changed +104.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$52.8M→$2.5M2 prior comparisons
Cost of revenue increased 16.6%
Cost of revenue changed +16.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$76.2M→$88.8M2 prior comparisons
Shares outstanding decreased 4.4%
Shares outstanding changed -4.4% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes. This reverses 3 consecutive comparable moves in the opposite direction.
45,839,728→43,808,3938 prior comparisons
SBC / revenue moved 137 bp higher
SBC / revenue changed +137 basis points from the comparable as-filed period.
1.54%→2.91%2 prior comparisons
Receivables / revenue moved 262 bp higher
Receivables / revenue changed +262 basis points from the comparable as-filed period.
86.52%→89.14%1 prior comparisons
Current liabilities increased 11.1%
Current liabilities changed +11.1% from the comparable as-filed period.
$245.4M→$272.6M1 prior comparisons
Selling, general & administrative increased 10.0%
Selling, general & administrative changed +10.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$61.0M→$67.2M2 prior comparisons
Total assets decreased 7.1%
Total assets changed -7.1% from the comparable as-filed period.
$2.0B→$1.9B1 prior comparisons
Working capital decreased 5.6%
Working capital changed -5.6% from the comparable as-filed period.
$433.0M→$408.8M1 prior comparisons
R&D / revenue moved 85 bp higher
R&D / revenue changed +85 basis points from the comparable as-filed period.
4.64%→5.49%2 prior comparisons
Gross profit increased 6.8%
Gross profit changed +6.8% from the comparable as-filed period.
$67.8M→$72.4M2 prior comparisons
Current ratio decreased 9.6%
Current ratio changed -9.6% from the comparable as-filed period.
2.76→2.51 prior comparisons
Current assets increased 0.4%
Current assets changed +0.4% from the comparable as-filed period.
$678.5M→$681.4M1 prior comparisons
Working capital / assets moved 34 bp higher
Working capital / assets changed +34 basis points from the comparable as-filed period.
21.45%→21.79%1 prior comparisons
Inventory decreased 1.8%
Inventory changed -1.8% from the comparable as-filed period.
$80.5M→$79.1M1 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.